SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

CPO Biologiques

» Start this Course
(Practice similar questions for free)
Question:

Ustekinumab (Stelara)

Author: Natalia Abesada



Answer:

Anti IL 12 et 23. Ind: psoriasis, arthite psoriasique, rectocolite hemorragique. EI: risque accru de cancer et d'infection (+EI du anti TNF alpha)


0 / 5  (0 ratings)

1 answer(s) in total